Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Merck & Co. Inc recalls Belsomra (suvorexant) tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
Products
  • Belsomra (suvorexant) tablets
Company
Merck & Co. Inc
Where it was sold

Nationwide in the USA and PR.

Nationwide

Units affected
51,320 cartons
About this recall
Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway, NJ 07065, USA, NDC 0006-0033-10 (Shellpack and Print Mat Labels), 0006-0033-30 (Carton Label)